Yahoo Web Search

Search results

    • Obesity Drug Leader In Buy Zone After Huge Gains

      Obesity Drug Leader In Buy Zone After Huge Gains

      Investor's Business Daily· 2 hours ago

      In March, Novo Nordisk agreed to acquire Cardior, a biotech firm that targets RNAs to treat heart disease. The anti-obesity drugs market is on a fast...